Investigation of circulating miR-182-3p, miR-382-3p and miR-93, miR-142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer …
E Aboutalebi Vand Beilankouhi, Z Sanaat… - Naunyn-Schmiedeberg's …, 2025 - Springer
Breast cancer (BC) commonly expresses estrogen receptors (ERs); hence, endocrine
therapy targeting ERs is considered an effective treatment. Tamoxifen (TAM) resistance is an …
therapy targeting ERs is considered an effective treatment. Tamoxifen (TAM) resistance is an …
Association of miRNA expression pattern with outcome of letrozole therapy in breast cancer patients
O Pridko, T Borikun, O Rossylna… - Experimental …, 2023 - exp-oncology.com.ua
Breast cancer (BC) remains the most prevalent tumor and the leading cause of death among
women worldwide, despite the advancements in diagnosis and new treatments. A significant …
women worldwide, despite the advancements in diagnosis and new treatments. A significant …
Synthesis and Evaluation of Chitosan/miR-125b-5p Nanoparticles for Targeting RAF-1 and BMPR1b Genes in MCF-7 Breast Cancer Cells
R Norouzi, N Abousalehi, AS Afshar - Russian Journal of Genetics, 2024 - Springer
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play
important roles in cancer development and progression. MiR-125b-5p is a miRNA that has …
important roles in cancer development and progression. MiR-125b-5p is a miRNA that has …
Utilizing OncomiR and TSmiR as Biomarkers for Screening Breast Cancer.
GL Phoebe M - Current Trends in Biotechnology & …, 2024 - search.ebscohost.com
Breast cancer stands out as a significant threat to women globally, emphasizing the urgent
need for reliable diagnostic and prognostic markers. Numerous studies have shown that …
need for reliable diagnostic and prognostic markers. Numerous studies have shown that …
PROSPECTS OF USING microRNAs AS PREDICTIVE MARKERS OF HORMONE-DEPENDENT BREAST CANCER
OS Pridko, AV Rusyn - oncology.kiev.ua
Hormone-dependent malignant neoplasms are the most common form of breast cancer (BC)
worldwide. The high heterogeneity of clinical manifestations and response to treatment …
worldwide. The high heterogeneity of clinical manifestations and response to treatment …